IANNITTO, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 909
EU - Europa 225
AS - Asia 134
OC - Oceania 8
AF - Africa 5
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.285
Nazione #
US - Stati Uniti d'America 907
IT - Italia 91
CN - Cina 51
GB - Regno Unito 47
SG - Singapore 32
IE - Irlanda 30
IN - India 28
SE - Svezia 14
DE - Germania 13
FI - Finlandia 13
AU - Australia 8
KR - Corea 7
RU - Federazione Russa 7
BE - Belgio 3
BR - Brasile 3
CI - Costa d'Avorio 3
JP - Giappone 3
BD - Bangladesh 2
CA - Canada 2
EG - Egitto 2
LK - Sri Lanka 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
SA - Arabia Saudita 2
TR - Turchia 2
UA - Ucraina 2
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
UZ - Uzbekistan 1
Totale 1.285
Città #
Fairfield 166
Woodbridge 97
Ashburn 77
Chandler 70
Seattle 70
Houston 67
Wilmington 67
Cambridge 57
Des Moines 27
Dublin 26
Singapore 23
Medford 19
Ann Arbor 17
Altamura 16
Dearborn 12
San Diego 12
Lawrence 11
Princeton 11
Nanjing 10
Palermo 8
Kumar 7
Boardman 6
Falls Church 6
Islington 6
Milan 6
Beijing 5
Hyderabad 5
Kolkata 5
Ludwigshafen am Rhein 5
Mumbai 5
Ningbo 5
Santa Clara 5
Birmingham 4
Hebei 4
Jinan 4
Limbiate 4
New York 4
Peterborough 4
Shenyang 4
Abidjan 3
Beaverton 3
Blackmans Bay 3
Bucheon-si 3
Cinisello Balsamo 3
Dawlish 3
Derby 3
Helsinki 3
London 3
Moscow 3
Nanchang 3
San Paolo di Civitate 3
São Paulo 3
Aberdeen 2
Antwerp 2
Bacolod City 2
Bracknell 2
Bundoora 2
Cairo 2
Chicago 2
Chignolo d'Isola 2
Clifton 2
Colombo 2
Columbus 2
Cork 2
Dhaka 2
Drogheda 2
Düsseldorf 2
East Northport 2
Exeter 2
Florence 2
Grays 2
Guangzhou 2
Hangzhou 2
Istanbul 2
Jeddah 2
Jiaxing 2
Jung-gu 2
Kinuta 2
Lappeenranta 2
Lucknow 2
Moio della Civitella 2
Montreal 2
Monzuno 2
Norwalk 2
Oslo 2
Penn Yan 2
Pittsburgh 2
Rome 2
Somerville 2
Subang Jaya 2
Tianjin 2
Tower Hamlets 2
Trento 2
Tulsa 2
Vassar 2
Vicenza 2
Vignolo 2
Zhengzhou 2
Abingdon 1
Ashurst Wood 1
Totale 1.090
Nome #
A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia 236
Use of intrapleural bortezomib in myelomatous pleural effusion [1] 140
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 140
Angioimmunoblastic T-cell lymphoma 126
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage hodgkin lymphoma in the pre-positron emission tomography era: A Gruppo Italiano Studio Linfomi (GISL) prospective trial 117
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 116
Gamma-delta T-cell lymphomas 109
Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin’s lymphoma patients? 104
Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations 104
Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach 75
Re: "Splenic marginal zone B-cell lymphoma associated with primary Sjögren's syndrome" 67
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study 14
Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle 14
Totale 1.362
Categoria #
all - tutte 5.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020282 0 0 0 0 46 59 47 34 39 22 22 13
2020/2021204 10 31 15 12 10 3 2 22 11 57 12 19
2021/2022161 21 30 2 0 10 5 11 4 20 26 9 23
2022/2023227 11 51 0 18 29 37 22 12 23 8 10 6
2023/2024167 4 16 21 8 17 24 14 3 8 19 4 29
2024/202581 14 28 8 23 8 0 0 0 0 0 0 0
Totale 1.362